One of the challenges with remote visits is the distribution, tracking, reconciliation and destruction of the investigational medicinal product (IMP), while maintaining the blinding and patient confidentiality.
TORONTO (PRWEB) March 29, 2021
The COVID-19 pandemic has accelerated the adoption of decentralized clinical trials (DCTs), which was already increasing due to the benefits of convenience, greater access to treatments by patients, greater access to a more representative population by investigators and reduced burden on site staff. One of the challenges with remote visits is the distribution, tracking, reconciliation and destruction of the investigational medicinal product (IMP), while maintaining the blinding and patient confidentiality. To address this challenge, operational and technological strategies have been implemented in many trials. However, interactive response technology (IRT) solution also has a big role to play in any solution required to support DCTs, today and in the future.
Join Susan Rizzo, Director, Service Delivery RTSM, Bioclinica in a live webinar on Thursday, April 15, 2021 at 11am EDT (4pm BST/UK) to hear about the role of interactive response technology in supporting decentralized clinical trials.
For more information, or to register for this event, visit Getting Investigational Drugs to Patients in Decentralized Clinical Trials: Solutions and Key IRT Considerations.
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.